Predictors of outcomes in patients with ascites, hyponatremia, and renal failure
Sumeet K. Asrani, Patrick S. Kamath – 21 June 2013 – Watch a video presentation of this article
Treatment of refractory ascites
Harjit Bhogal, Arun J. Sanyal – 21 June 2013 – Watch a video presentation of this article
Renal failure and liver transplantation
Thomas D. Boyer, Bruce Kaplan – 21 June 2013 – Watch a video presentation of this article
Treatment of refractory ascites
Harjit Bhogal, Arun J. Sanyal – 21 June 2013 – Watch a video presentation of this article
Relationship between systemic hemodynamics, renal dysfunction, and fluid retention in cirrhosis
Vicente Arroyo, Javier Fernández – 21 June 2013 – Watch a video presentation of this article
Improving quality of care in patients with cirrhosis
Fasiha Kanwal, Hashem El‐Serag – 21 June 2013 – Watch a video presentation of this article
Predictors of outcomes in patients with ascites, hyponatremia, and renal failure
Sumeet K. Asrani, Patrick S. Kamath – 21 June 2013 – Watch a video presentation of this article
Current treatment strategies for hepatorenal syndrome
Elsa Solà, Mónica Guevara, Pere Ginès – 21 June 2013 – Watch a video presentation of this article
Workup of nonalcoholic fatty liver disease
Shih‐Wei Lai, Kuan‐Fu Liao – 21 June 2013 – Watch a video presentation of this article
Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B
Robert Perrillo, Maria Buti, Francois Durand, Michael Charlton, Adrian Gadano, Guido Cantisani, Che‐Chuan Loong, Kimberly Brown, Wenhua Hu, Juan Carlos Lopez‐Talavera, Cyril Llamoso – 21 June 2013 – For patients undergoing liver transplantation (LT) for hepatitis B virus (HBV)–related liver disease, the current standard of care for preventing reinfection of the allograft is nucleoside analogue therapy combined with hepatitis B immune globulin (HBIG).